Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC)
To learn if belzutifan can help to control the disease in patients with metastatic RCC who are considered candidates for active surveillance and have not under…
Active SurveillanceClear Cell Renal Cell Carcinoma
Estimated
~$10 – $6,250
M.D. Anderson Cancer CenterNCT07023432
Phase 2
Phase II Trial of In-Situ Autologous Vaccination With Intratumoral and Systemic Hiltonol® (Poly-ICLC) Administered to Prostate Cancer Patients on Active Surveillance
This is a partially blinded randomized controlled phase II pilot study comparing Poly-ICLC (Hiltonol®) treatment vs no treatment, for prostate cancer participa…
Prostate Cancer Patients on Active Surveillance
Estimated
~$10 – $7,500
Ashutosh Kumar TewariNCT06343077